UNSPSC 51373456: Codeine/potassium guaiacolsulfonate/promethazine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373456 Codeine/potassium guaiacolsulfonate/promethazine is a Commodity code that captures pharmaceutical and controlled-substance procurement by state and local health and corrections agencies. Recent solicitations under this code show state and local governments buying parenteral solutions, intravenous medications, naloxone, and drug management systems to support incarcerated populations and community health initiatives. The Washington State Department of Corrections issued RFQ RFQQK13020 for parenteral products, services, and equipment—including TPN and PPN solutions, IV solutions, and controlled substances for medically necessary healthcare—to supply eight correctional facilities across the state, with a due date of October 7, 2026 and a pre-bid conference on September 23, 2026. The scope spans three regions and anticipates selecting up to three contractors per region under a contract term running November 26, 2026 through June 30, 2030 with discretionary extension rights. DOC emphasizes set-asides and aspirational goals for small, minority-owned, women-owned, and veteran-owned businesses, with a Subcontractor Inclusion Plan requirement for primes to identify qualified diverse subcontractors. Bidders must demonstrate documented experience with IV solution preparation, patient lab monitoring, and pharmacy delivery logistics, including 24-hour turnaround on compounded PN bags and 8-hour delivery on other parenteral products.

State corrections and county health departments drive the recent activity under this code. The Washington State Department of Corrections and Seminole County, Florida both posted solicitations in the recent period. Washington state shows the strongest current activity; Seminole County's June 2026 posting for naloxone and drug deactivation systems (1,900 units annually via IFB 60459723LAS, due July 26, 2026) signals activity in Florida as well. The Washington DOC procurement requires Washington State business licensure and Washington State Patrol NCIC clearance for all service personnel, with substantial insurance requirements including $1 million commercial general liability and $2 million cyber liability. Pricing in the Washington solicitation is firm for the initial two-year term and remains fixed for 150 days following bid receipt. Bidders pursuing state corrections and public health agency work under this code should expect rigorous credentialing, fast delivery requirements, and strong preference compliance obligations where applicable.